Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in advanced molecular imaging technology and comprehensive PET imaging solutions, today announced three new orders for its ...
GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...
A newly developed cardiac PET imaging technique offers a simpler way to detect significant coronary artery disease—eliminating the need for complex scanning protocols. This innovative approach, which ...
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT ...
Based on the clinical and scientific evidence now available, there are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded.” — Timothy Bateman, ...
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an exclusive partnership with Cardiac Imaging, Inc.
Cardiovascular disease continues to be the leading cause of death worldwide. To save lives, constantly improving diagnostic and risk assessments is vital. One researcher from the University of ...
A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment. Using this strategy, researchers demonstrated the ...
A patient with a prolonged history of shoulder pain attributed to arthritis, sought medical attention. Because this pain could also be a sign of cardiovascular issues, the physician recommended an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results